Fidelity Investments’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.9K | Buy |
332
+3
| +0.9% | +$460 | ﹤0.01% | 3895 |
|
|
2025
Q1 | $51.8K | Sell |
329
-53
| -14% | -$8.34K | ﹤0.01% | 3846 |
|
|
2024
Q4 | $59.9K | Sell |
382
-30
| -7% | -$4.7K | ﹤0.01% | 3758 |
|
|
2024
Q3 | $73K | Buy |
412
+39
| +10% | +$6.91K | ﹤0.01% | 3601 |
|
|
2024
Q2 | $62.8K | Buy |
373
+33
| +10% | +$5.55K | ﹤0.01% | 3494 |
|
|
2024
Q1 | $56.6K | Buy |
340
+170
| +100% | +$28.3K | ﹤0.01% | 3520 |
|
|
2023
Q4 | $28K | Buy |
170
+61
| +56% | +$10.1K | ﹤0.01% | 3777 |
|
|
2023
Q3 | $16.9K | Hold |
109
| – | – | ﹤0.01% | 3891 |
|
|
2023
Q2 | $17K | Sell |
109
-67
| -38% | -$10.4K | ﹤0.01% | 3939 |
|
|
2023
Q1 | $28.6K | Sell |
176
-35
| -17% | -$5.68K | ﹤0.01% | 3685 |
|
|
2022
Q4 | $33.6K | Buy |
211
+177
| +521% | +$28.2K | ﹤0.01% | 3583 |
|
|
2022
Q3 | $5K | Sell |
34
-2
| -6% | -$294 | ﹤0.01% | 4293 |
|
|
2022
Q2 | $5K | Sell |
36
-73
| -67% | -$10.1K | ﹤0.01% | 4297 |
|
|
2022
Q1 | $18K | Sell |
109
-15
| -12% | -$2.48K | ﹤0.01% | 4043 |
|
|
2021
Q4 | $23K | Buy |
124
+4
| +3% | +$742 | ﹤0.01% | 3420 |
|
|
2021
Q3 | $24K | Buy |
120
+54
| +82% | +$10.8K | ﹤0.01% | 3383 |
|
|
2021
Q2 | $13K | Buy |
66
+13
| +25% | +$2.56K | ﹤0.01% | 3480 |
|
|
2021
Q1 | $9K | Sell |
53
-57
| -52% | -$9.68K | ﹤0.01% | 3399 |
|
|
2020
Q4 | $18K | Buy |
110
+23
| +26% | +$3.76K | ﹤0.01% | 3196 |
|
|
2020
Q3 | $14K | Sell |
87
-62
| -42% | -$9.98K | ﹤0.01% | 3127 |
|
|
2020
Q2 | $24K | Sell |
149
-228
| -60% | -$36.7K | ﹤0.01% | 2943 |
|
|
2020
Q1 | $48K | Buy |
377
+76
| +25% | +$9.68K | ﹤0.01% | 2775 |
|
|
2019
Q4 | $42K | Sell |
301
-141
| -32% | -$19.7K | ﹤0.01% | 2931 |
|
|
2019
Q3 | $52K | Buy |
442
+342
| +342% | +$40.2K | ﹤0.01% | 2852 |
|
|
2019
Q2 | $13K | Hold |
100
| – | – | ﹤0.01% | 3170 |
|
|
2019
Q1 | $13K | Buy |
100
+99
| +9,900% | +$12.9K | ﹤0.01% | 3065 |
|
|
2018
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 3522 |
|